Selective Estrogen Receptor Modulators (serms) - Toxicology

Relevant Publications

New potential selective estrogen receptor modulators in traditional Chinese medicine for treating menopausal syndrome.

Issue Release: 2024

Beyond breast cancer: role of selective estrogen receptor modulators in reducing systemic malignancies-evidence from population-based data.

Issue Release: 2024

Improving Tamoxifen Performance in Inducing Apoptosis and Hepatoprotection by Loading on a Dual Nanomagnetic Targeting System.

Issue Release: 2024

Next generation selective estrogen receptor degraders in postmenopausal women with advanced-stage hormone receptors-positive, HER2-negative breast cancer.

Issue Release: 2024

Estrogen signalling and Alzheimer\'s disease: Decoding molecular mechanisms for therapeutic breakthrough.

Issue Release: 2024

Identification of Novel Inhibitors for ERα Target of Breast Cancer By In Silico Approach.

Issue Release: 2024

Incidence and severity of medication-related osteonecrosis of the jaw in patients with osteoporosis using data from a Korean nationwide sample cohort in 2002 to 2019: a retrospective study.

Issue Release: 2024

Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature.

Issue Release: 2024

Pharmacological insights on novel oral selective estrogen receptor degraders in breast cancer.

Issue Release: 2024

Non-genomic ERα-AMPK signaling regulates sex-dependent Bcrp transport activity at the blood-brain barrier.

Issue Release: 2024

Fibroblast stromal support model for predicting human papillomavirus-associated cancer drug responses.

Issue Release: 2024

Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules.

Issue Release: 2024

Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.

Issue Release: 2024

Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer.

Issue Release: 2024

Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells.

Issue Release: 2024

Selective Estrogen Receptor Modulators\' (SERMs) Influence on Expression in Breast Cancer Cell Lines with Distinct Biological Subtypes.

Issue Release: 2024

The anti-aromatase and anti-estrogenic activity of plant products in the treatment of estrogen receptor-positive breast cancer.

Issue Release: 2024

Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S ESR1 Mutant Breast Cancer Cells.

Issue Release: 2024

Pyrimidine-triazole-tethered tert-butyl-piperazine-carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β-catenin activation.

Issue Release: 2024

Low-molecular-weight estrogenic phytoprotein suppresses osteoporosis development through positive modulation of skeletal estrogen receptors.

Issue Release: 2024

How do PCSK9 Inhibitors function?

What Are the Limitations of Ion Exchange in Toxicology?

Are there specific populations that should avoid PCSK9 Inhibitors?

What Is the Role of Government and Regulations?

Why are Unstable Chemicals Significant in Toxicology?

What are the Common Types of Analytical Instruments Used?

What are Safety Thresholds?

How Can Biological Factors Modulate Toxicity?

Why is the G1 Phase Important in Toxicity Testing?

What is LDL Cholesterol?

Selective Estrogen Receptor Modulators (serms) - Toxicology

Relevant Publications

Partnered Content Networks

Relevant Topics